127 related articles for article (PubMed ID: 21861805)
1. Potential new anticancer molecular targets for the treatment of human testicular seminomas.
Chieffi P
Mini Rev Med Chem; 2011 Oct; 11(12):1075-81. PubMed ID: 21861805
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets for the treatment of testicular germ cell tumors.
Chieffi P
Mini Rev Med Chem; 2007 Jul; 7(7):755-9. PubMed ID: 17627586
[TBL] [Abstract][Full Text] [Related]
3. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
4. Bisphenol A promotes testicular seminoma cell proliferation through GPER/GPR30.
Chevalier N; Bouskine A; Fenichel P
Int J Cancer; 2012 Jan; 130(1):241-2. PubMed ID: 21312194
[No Abstract] [Full Text] [Related]
5. Synthesis of a novel platinum(II) complex with 6,7-dichloro-5,8-quinolinedione and the study of its antitumor mechanism in testicular seminoma.
Li Z; Zhou J; Gan Y; Yin Y; Zhang W; Yang J; Tang Y; Dai Y
J Inorg Biochem; 2019 Aug; 197():110701. PubMed ID: 31055215
[TBL] [Abstract][Full Text] [Related]
6. New prognostic markers and potential therapeutic targets in human testicular germ cell tumors.
Chieffi P
Curr Med Chem; 2011; 18(33):5033-40. PubMed ID: 22050751
[TBL] [Abstract][Full Text] [Related]
7. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
8. [KIT receptor in testicular seminoma].
Paule B
Prog Urol; 2005 Feb; 15(1):96-9; discussion 99. PubMed ID: 15822404
[TBL] [Abstract][Full Text] [Related]
9. Testicular germ-cell cancer.
Horwich A; Shipley J; Huddart R
Lancet; 2006 Mar; 367(9512):754-65. PubMed ID: 16517276
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin for stage I seminoma and the sword of Damocles.
Loehrer PJ; Bosl GJ
J Clin Oncol; 2005 Dec; 23(34):8566-9. PubMed ID: 16260692
[No Abstract] [Full Text] [Related]
11. Treating IIA/B seminoma with combination carboplatin and radiotherapy.
Gilbert DC; Vanas NJ; Beesley S; Bloomfield D; Money-Kyrle J; Norman A; Dearnaley D; Horwich A; Huddart RA
J Clin Oncol; 2009 Apr; 27(12):2101-2; author reply 2102-3. PubMed ID: 19289608
[No Abstract] [Full Text] [Related]
12. Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: an overview.
Chieffi P; Chieffi S
J Cell Physiol; 2013 Aug; 228(8):1641-6. PubMed ID: 23359388
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin does not prevent contralateral testicular tumors in patients with seminoma.
Dieckmann KP; Matthies C; Kliesch S
J Clin Oncol; 2011 Jul; 29(21):2944-5; author reply 2945-6. PubMed ID: 21670458
[No Abstract] [Full Text] [Related]
14. The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.
Nettersheim D; Gillis A; Biermann K; Looijenga LH; Schorle H
Genes Chromosomes Cancer; 2011 Dec; 50(12):1033-42. PubMed ID: 21987446
[TBL] [Abstract][Full Text] [Related]
15. Germ cell tumors. Case 2. Unusual course of pure testicular seminoma.
Gholam D; Lotz JP; Atallah D; Theodore C
J Clin Oncol; 2004 May; 22(9):1755-6. PubMed ID: 15118000
[No Abstract] [Full Text] [Related]
16. [Radiotherapy of testicular seminoma: changes over the past 10 years].
Mirimanoff RO
Cancer Radiother; 2003 Nov; 7 Suppl 1():70s-77s. PubMed ID: 15124547
[TBL] [Abstract][Full Text] [Related]
17. Retrospective multicentre study of carboplatin monotherapy for clinical stage I seminoma.
Steiner H; Scheiber K; Berger AP; Rein P; Hobisch A; Aufderklamm J; Pilloni S; Stoehr B; Aigner F; Fritzer A; Zangerl F
BJU Int; 2011 Apr; 107(7):1074-9. PubMed ID: 21438975
[TBL] [Abstract][Full Text] [Related]
18. Leptin Receptor as a Potential Target to Inhibit Human Testicular Seminoma Growth.
Panza S; Gelsomino L; Malivindi R; Rago V; Barone I; Giordano C; Giordano F; Leggio A; Comandè A; Liguori A; Aquila S; Bonofiglio D; Andò S; Catalano S
Am J Pathol; 2019 Mar; 189(3):687-698. PubMed ID: 30610844
[TBL] [Abstract][Full Text] [Related]
19. Post-chemotherapy residual mass in stage IIC seminomatous testicular tumor.
Ahmad NA; Biyabani SR; Abbas F
J Pak Med Assoc; 2002 Dec; 52(12):576-8. PubMed ID: 12627908
[No Abstract] [Full Text] [Related]
20. The sword of Damocles and the treatment of stage I seminoma.
Oliver T; Mead G; Mason M; Stenning S; Dieckmann K; Steiner H; De Santis M; Aparicio J; Skoneczna I; Kratzik C
J Clin Oncol; 2006 Jun; 24(16):2599-600. PubMed ID: 16735720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
